Strut Health vs Live Vital
Strut Health advertises a monthly injection vial on auto-refill; Live Vital uses a ten-week protocol label. These are different purchase periods.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Strut Health
Partner
$129/mo
Semaglutide comes as a monthly injection vial or a 30-day buccal lozenge; the current oral rate is higher. Tirzepatide injection includes B6. Prescriptions renew by refill schedule, and cancellation needs at least 48 hours' notice before processing.
- Product cards distinguish the formulation and supplied period
- Prices are visible before clinical intake
- Both ingredients are offered in injectable and lozenge forms
- The FAQ describes how to pause, delay or cancel refills
- Prescription charges recur until paused or canceled
- The FAQ requires forty-eight hours of cancellation notice before processing
- The final prescription and price depend on consultation
- Medication availability and consultation requirements vary by state
Pick it for: Comparing a recurring monthly-vial offer
Not for: Anyone relying on a guaranteed one-off price or a universal no-video intake.
Live Vital
Partner
$130/mo
The ten-week protocol total is more useful than the monthly headline. Both GLP-1 pages explicitly describe compounded injections. Confirm the prescribed supply, dispensing pharmacy and next charge; the protocol label does not establish that billing stops.
- The protocol total is published beside the rate
- The advertised protocol length is stated
- Product pages identify weekly injections
- The site describes physician review
- A ten-week protocol is priced as three months
- Renewal arrangements need clarification before purchase
- The refund policy contains unfinished policy text
- Compounding pharmacy is not named
Pick it for: Comparing a ten-week label with its next-charge terms
Not for: Anyone comparing advertised monthly figures at face value.
Our verdict
Strut Health lists semaglutide injection at $129 for a monthly vial; Live Vital advertises a compounded semaglutide ten-week protocol at $299 total if prescribed. Those labels do not establish matched doses, supplied quantities or complete treatment costs. Strut's prescription charges recur by refill schedule, and its FAQ requires at least 48 hours' cancellation notice before processing. Live Vital's reviewed policies do not establish whether the selected protocol renews automatically or stops. Compare the prescribed supply and next charge in writing, rather than treating one headline as the cheaper month.
What actually separates them
Strut Health and Live Vital differ on published price. The table summarizes those terms; confirm any details it does not cover with the provider.
Live Vital’s comparison figure is $1 higher than Strut Health’s — a 1% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $1,548 at Strut Health against $1,560 at Live Vital — a difference of $12. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| Strut Health | Live Vital | |
|---|---|---|
| Published price | $129/mo | $130/mo |
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
Before you choose either
The providers describe different service areas. Live Vital lists 1 that Strut Health does not list — AR. Confirm your location and selected medication directly. A provider-wide footprint does not establish every treatment’s availability.
Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.